# LAI-PrEP Bridge Period Decision Tool
## Complete Resource Package - User Guide

---

## ðŸ“š What's Included in This Package

This package contains **7 comprehensive resources** to help clinicians, healthcare administrators, and patients successfully navigate the LAI-PrEP bridge period. All resources are based on the manuscript "Bridging the Gap: The PrEP Cascade Paradigm Shift for Long-Acting Injectable HIV Prevention" (Demidont & Backus, 2025).

---

## ðŸŽ¯ Quick Start: Which Resource Do I Need?

### **I'm a clinician seeing patients today**
â†’ Start with: **QUICK_REFERENCE_CARD.md** (1 page)
- Keep at your workstation
- Fast risk assessment
- Quick intervention selection
- 30-second decision-making

### **I need to understand the tool but don't code**
â†’ Start with: **NON_TECHNICAL_GUIDE.md** (comprehensive)
- Plain language explanation
- Real-world examples
- No coding knowledge needed
- Step-by-step instructions

### **I want to implement LAI-PrEP at my clinic**
â†’ Start with: **IMPLEMENTATION_CHECKLIST.md** (phased approach)
- Week-by-week action steps
- Resource requirements
- Success metrics
- Troubleshooting guide

### **I need help with a specific patient decision**
â†’ Start with: **DECISION_FLOWCHART.md** (visual guide)
- Step-by-step flowchart
- Population-specific pathways
- Decision trees
- Special population fast tracks

### **I want to give information to patients**
â†’ Start with: **PATIENT_HANDOUT.md** (patient-facing)
- Simple language
- What to expect
- How to get help
- Motivational support

### **I'm a developer/data analyst**
â†’ Start with: **README_LAI_PrEP_Tool.md** and **lai_prep_decision_tool.py**
- Technical documentation
- Code implementation
- API reference
- Customization options

---

## ðŸ“„ Detailed Resource Descriptions

### 1. **QUICK_REFERENCE_CARD.md** â­ START HERE FOR CLINICAL USE
**Format**: 1-page reference card  
**Audience**: Busy clinicians  
**Use Case**: At point of care during patient visits  
**Time to Review**: 5 minutes  

**What's Inside**:
- 4-step risk assessment (30 seconds)
- Intervention selection matrix
- Quick decision grid by patient type
- Essential phone numbers to post
- Keep at your workstation!

**Best For**:
- Quick decisions during clinic
- Front-line providers
- Medical assistants doing intake
- Nurses administering injections

---

### 2. **NON_TECHNICAL_GUIDE.md** â­ COMPREHENSIVE EDUCATION
**Format**: 35+ page comprehensive guide  
**Audience**: Anyone without coding experience  
**Use Case**: Understanding the tool and bridge period concept  
**Time to Review**: 45-60 minutes  

**What's Inside**:
- What the tool is and why it matters
- Understanding the bridge period
- How the tool works (step-by-step)
- Real-world examples with interpretation
- Population-specific guidance
- Quick reference tables
- FAQs and troubleshooting
- Action steps for your clinic

**Best For**:
- New to LAI-PrEP
- Clinic managers
- Quality improvement teams
- Grant writers
- Anyone who needs deep understanding

**Key Sections**:
- Page 1-5: Introduction and bridge period concept
- Page 6-15: How the tool works (no coding)
- Page 16-25: Real-world examples
- Page 26-30: Reference tables
- Page 31-35: Implementation guidance

---

### 3. **IMPLEMENTATION_CHECKLIST.md** â­ PROGRAM DEVELOPMENT
**Format**: Phased implementation checklist  
**Audience**: Clinic administrators, program managers  
**Use Case**: Building LAI-PrEP program from scratch  
**Time to Review**: 30 minutes  

**What's Inside**:
- Phase 1: Week 1 immediate actions (easy wins)
- Phase 2: Weeks 2-4 core infrastructure
- Phase 3: Months 2-3 expanded services
- Phase 4: Months 3-6 optimization
- Phase 5: Ongoing sustainability
- Resource requirements by program size
- Success indicators and metrics
- Troubleshooting common problems

**Best For**:
- Starting new LAI-PrEP program
- Improving existing program
- Securing funding/resources
- Training new staff
- Quality improvement projects

**Phases**:
- âœ“ **Phase 1** (Week 1): Easy wins with oral PrEP patients
- âœ“ **Phase 2** (Month 1): Navigation, testing, insurance
- âœ“ **Phase 3** (Month 2-3): Population-specific support
- âœ“ **Phase 4** (Month 3-6): Peer navigation, partnerships
- âœ“ **Phase 5** (Ongoing): Quality review and equity

---

### 4. **DECISION_FLOWCHART.md** â­ VISUAL DECISION-MAKING
**Format**: Text-based flowcharts and decision trees  
**Audience**: Visual learners, clinical decision support  
**Use Case**: Walking through individual patient decisions  
**Time to Review**: 15 minutes  

**What's Inside**:
- Step-by-step visual flowchart
- Population assessment pathway
- Risk categorization branches
- Intervention selection matrix
- Implementation & follow-up timeline
- Special population fast tracks (PWID, adolescents, oral PrEP)
- Clinical pearls

**Best For**:
- Training new staff
- Complex cases
- Visual learners
- Protocol development
- Quality assurance

**Special Features**:
- ASCII flowcharts (viewable in any text editor)
- Clear decision points
- Action items at each step
- Population-specific shortcuts

---

### 5. **PATIENT_HANDOUT.md** â­ PATIENT EDUCATION
**Format**: Patient-facing educational handout  
**Audience**: Patients starting LAI-PrEP  
**Use Case**: Give to every patient at prescription visit  
**Time to Review**: 10 minutes (for patients)  

**What's Inside**:
- What is LAI-PrEP (simple language)
- What to expect (timeline)
- How to get help with barriers
- When to call the clinic
- FAQs from patients' perspective
- Motivational support
- Contact information template

**Best For**:
- Every patient prescribed LAI-PrEP
- Reducing no-shows
- Patient empowerment
- Setting expectations
- Improving communication

**Print & Customize**:
- Add your clinic logo
- Fill in contact information
- Print on letterhead
- Available in English (Spanish translation recommended)

---

### 6. **README_LAI_PrEP_Tool.md** â­ TECHNICAL DOCUMENTATION
**Format**: Technical documentation  
**Audience**: Developers, IT staff, data analysts  
**Use Case**: Understanding the Python code  
**Time to Review**: 20 minutes  

**What's Inside**:
- Overview of code functionality
- Installation instructions
- API reference
- Usage examples
- Customization guide
- Evidence base
- Citation information

**Best For**:
- IT implementation
- Electronic health record integration
- Custom dashboards
- Research applications
- Data analysis

---

### 7. **lai_prep_decision_tool.py** â­ EXECUTABLE CODE
**Format**: Python script  
**Audience**: Developers, technical users  
**Use Case**: Running the actual decision support tool  
**Requirements**: Python 3.7+  

**What's Inside**:
- Complete decision support algorithm
- Population-specific risk calculations
- Intervention recommendation engine
- Report generation
- Example cases
- Extensible architecture

**To Run**:
```bash
python3 lai_prep_decision_tool.py
```

**Output**: 
- Detailed risk assessments
- Prioritized interventions
- Success predictions
- Clinical guidance notes

---

## ðŸŽ“ Recommended Learning Path

### **For Clinicians (New to LAI-PrEP)**

1. **Day 1**: Read QUICK_REFERENCE_CARD.md (5 min)
   - Understand the basic problem
   - Learn quick assessment
   
2. **Week 1**: Read NON_TECHNICAL_GUIDE.md sections:
   - Introduction (pages 1-5)
   - Real-world examples (pages 16-25)
   - Quick reference tables (pages 26-30)
   
3. **Week 2**: Review DECISION_FLOWCHART.md
   - Practice with recent patients
   - Identify where your patients would fall
   
4. **Ongoing**: Use QUICK_REFERENCE_CARD.md at point of care

**Time Investment**: ~2 hours total

---

### **For Program Managers (Building LAI-PrEP Program)**

1. **Week 1**: Read NON_TECHNICAL_GUIDE.md (full)
   - Understand evidence base
   - Learn what works
   
2. **Week 2**: Review IMPLEMENTATION_CHECKLIST.md
   - Assess current state
   - Identify quick wins
   - Plan phases
   
3. **Week 3**: Begin Phase 1 implementation
   - Focus on oral PrEP patients
   - Set up basic tracking
   
4. **Month 2-6**: Progress through phases
   - Build incrementally
   - Measure outcomes
   - Adjust based on data

**Time Investment**: ~4 hours reading + ongoing implementation

---

### **For Healthcare Systems (Multi-Site Implementation)**

1. **Planning Phase** (Month 1):
   - Leadership reads NON_TECHNICAL_GUIDE.md
   - Review IMPLEMENTATION_CHECKLIST.md with all sites
   - Assess resources and readiness
   
2. **Pilot Phase** (Month 2-3):
   - Implement at 1-2 sites
   - Use all resources
   - Collect data
   - Refine approach
   
3. **Scale Phase** (Month 4-6):
   - Roll out to remaining sites
   - Share lessons learned
   - Standardize protocols
   - Ongoing quality improvement

**Time Investment**: Leadership 8 hours, site teams 16 hours

---

## ðŸ“Š How to Measure Success

### Track These Metrics (From Your Data)

**Primary Outcome**:
- **Initiation Rate**: % of prescriptions resulting in first injection
  - Baseline: 53% (national average)
  - Target: >70%
  - Oral-to-injectable target: >85%

**Secondary Outcomes**:
- **Bridge Duration**: Days from prescription to injection
  - Target: <14 days (oral PrEP transitions)
  - Target: <28 days (PrEP-naive patients)
  
- **Population-Specific Rates**:
  - Track by: MSM, women, adolescents, PWID, transgender
  - Identify disparities
  - Target: <10% variation between groups

**Process Metrics**:
- Navigator contact within 24 hours: >90%
- HIV test turnaround time: <3 days
- Insurance authorization time: <7 days
- Appointment no-show rate: <20%

### Compare to Benchmarks

| Metric | National Baseline | Your Current | Your Target |
|--------|-------------------|--------------|-------------|
| Overall initiation | 53% | ___% | >70% |
| Oral-to-injectable | 85-90% (estimated) | ___% | >85% |
| MSM initiation | ~55% | ___% | >70% |
| Women initiation | ~45% | ___% | >65% |
| Adolescent initiation | ~35% | ___% | >50% |
| PWID initiation | ~25% | ___% | >35% |
| Bridge duration | Unknown | ___ days | <21 days |

---

## ðŸ”§ Customization & Adaptation

### All Documents Are Customizable

**You can**:
- Add your clinic logo and branding
- Update contact information
- Modify for local context
- Translate to other languages
- Adjust resource estimates for your setting
- Add local referral information

**Please maintain**:
- Attribution to original manuscript
- Evidence base citations
- Core recommendations (modify intensity, not recommendations themselves)

### Suggested Modifications by Setting

**Academic Medical Center**:
- Emphasize research opportunities
- Highlight trainee involvement
- Add quality metrics to dashboards

**Community Health Center**:
- Emphasize payment programs
- Focus on equity metrics
- Highlight community partnerships

**Private Practice**:
- Emphasize efficiency
- Focus on oral PrEP transitions
- Simplified tracking

**Health Department**:
- Population health perspective
- Policy recommendations
- System-level coordination

---

## ðŸ’¡ Quick Wins You Can Implement TODAY

Even before reading everything, you can:

### âœ“ **Immediate Action 1**: Identify Oral PrEP Patients
- Pull EHR report of current oral PrEP patients
- These are your easiest wins (85-90% success rate)
- Start transition conversations this week

### âœ“ **Immediate Action 2**: Print Quick Reference Card
- Print QUICK_REFERENCE_CARD.md
- Post at workstations
- Use in clinic today

### âœ“ **Immediate Action 3**: Set Up Basic Tracking
- Create simple spreadsheet
- Track: Date prescribed, Population, Date injected (or why not)
- Enter every LAI-PrEP prescription

### âœ“ **Immediate Action 4**: Designate Bridge Period Champion
- Assign one person to own the process
- Even 4 hours/week makes a difference
- Their job: Make sure prescribed patients get injected

---

## â“ Common Questions

### "Is this validated?"

The tool is based on published evidence from:
- >15,000 clinical trial participants (HPTN 083, 084, PURPOSE-1, PURPOSE-2)
- Real-world implementation data (53% initiation rate)
- Patient navigation literature (10-40% improvement in cancer care)
- Specific LAI-PrEP implementation studies

Population-specific projections are based on trial data and implementation science principles. The tool provides evidence-based estimates, not guarantees.

### "Do I need the Python code?"

**No!** The non-technical resources (especially NON_TECHNICAL_GUIDE.md and QUICK_REFERENCE_CARD.md) provide everything you need to apply the decision-making framework without any coding.

The Python code is provided for:
- Organizations wanting automated decision support
- Integration with electronic health records
- Research applications
- Customized dashboards

Most clinicians will never touch the code.

### "How long does this take to implement?"

**Minimal implementation**: 1-2 weeks
- Use QUICK_REFERENCE_CARD.md
- Assign bridge period champion
- Start tracking

**Full implementation**: 3-6 months
- Follow IMPLEMENTATION_CHECKLIST.md
- Build navigation program
- Establish partnerships

**The tool itself**: <5 minutes per patient
- Risk assessment: 30 seconds
- Intervention selection: 2 minutes
- Documentation: 2 minutes

### "What if we don't have resources for navigation?"

Start small:
- Begin with just tracking (0 cost)
- Focus on oral PrEP transitions (easiest wins)
- Assign existing staff 0.25 FTE (10 hours/week)
- Apply for grants using IMPLEMENTATION_CHECKLIST.md as template

Even minimal navigation (4-8 hours/week) improves outcomes significantly.

### "How do we convince leadership this matters?"

Use these talking points:
1. **Current failure rate**: 47% of prescriptions never result in injection
2. **Clinical impact**: LAI-PrEP >96% effective but only if people start
3. **Efficiency argument**: Better initiation = less retention support needed
4. **Equity imperative**: Vulnerable populations have highest attrition
5. **Return on investment**: Every dollar in navigation saves in retention costs

Show leadership the data in NON_TECHNICAL_GUIDE.md.

---

## ðŸ“ž Support & Resources

### Need Help?

**Clinical Questions**:
- National Clinician Consultation Center: nccc.ucsf.edu
- PrEP Hotline: 1-855-HIV-PREP

**Implementation Support**:
- Your regional AETC (AIDS Education and Training Center)
- State/local health department HIV prevention program

**Technical Issues**:
- Document bugs or suggestions in feedback to manuscript authors

**Training**:
- AETC National Coordinating Resource Center
- Local implementation collaboratives

---

## ðŸŽ¯ Success Story Example

**Example Clinic: "From 50% to 78% Initiation in 6 Months"**

**Baseline** (No intervention):
- 20 LAI-PrEP prescriptions
- 10 patients initiated (50%)
- No tracking of attrition reasons

**After Implementation**:
- Identified 30 oral PrEP patients for transition
- 26 successfully transitioned (87%)
- Added navigation program
- 28 new prescriptions (PrEP-naive)
- 20 initiated (71%)
- **Overall: 46/58 = 78% initiation rate**

**What They Did**:
1. Week 1: Used QUICK_REFERENCE_CARD.md, identified oral PrEP patients
2. Month 1: Hired 0.5 FTE navigator
3. Month 2: Implemented text reminders
4. Month 3: Added transportation support
5. Month 4-6: Refined based on data

**Cost**: $35,000/year for navigation program
**Return**: 18 additional patients on highly effective prevention

---

## ðŸ“ˆ Next Steps

### Today:
- [ ] Print QUICK_REFERENCE_CARD.md
- [ ] Skim NON_TECHNICAL_GUIDE.md introduction
- [ ] Identify one oral PrEP patient to transition

### This Week:
- [ ] Read relevant sections of NON_TECHNICAL_GUIDE.md
- [ ] Review DECISION_FLOWCHART.md
- [ ] Set up basic tracking
- [ ] Assign bridge period champion

### This Month:
- [ ] Complete IMPLEMENTATION_CHECKLIST.md Phase 1
- [ ] Start measuring initiation rates
- [ ] Begin population-specific interventions

### This Quarter:
- [ ] Progress through implementation phases
- [ ] Review outcomes
- [ ] Refine approach
- [ ] Celebrate wins!

---

## ðŸ“š Additional Reading

**Original Manuscript**:
Demidont, A.C.; Backus, K. (2025). Bridging the Gap: The PrEP Cascade Paradigm Shift for Long-Acting Injectable HIV Prevention. *Viruses*, 1, 0.

**Key Clinical Trials**:
- HPTN 083 (Landovitz et al., 2021) - Cabotegravir in MSM
- HPTN 084 (Delany-Moretlwe et al., 2022) - Cabotegravir in women
- PURPOSE-1 (Bekker et al., 2024) - Lenacapavir in women
- PURPOSE-2 (Ogbuagu et al., 2024) - Lenacapavir in diverse populations

**Implementation Studies**:
- CAN Community Health Network Study (Patel et al., 2023)
- San Francisco PrEP Navigation (Chan et al., 2018)
- Trio Health Persistence Data (2024)

---

## ðŸŒŸ Final Thoughts

The LAI-PrEP bridge period is a **solvable problem**. We know what works:
- Prioritize oral PrEP transitions (85-90% success)
- Use patient navigation for high-risk populations (+15% improvement)
- Remove structural barriers (transportation, childcare, insurance)
- Harm reduction approach for PWID (essential)
- Measure and improve continuously

**You don't need to implement everything at once.** Start with quick wins, measure your progress, and build incrementally.

**The goal**: Get more people successfully started on this highly effective prevention tool.

**The reality**: With proactive intervention, you CAN achieve >70% initiation rates.

**The impact**: Every patient who successfully initiates is a life potentially saved from HIV.

---

*This resource package was created to make LAI-PrEP implementation accessible to everyone - from front-line clinicians to healthcare administrators to policy makers. Use what works for you, adapt what doesn't, and please share your successes with others working on HIV prevention.*

**Good luck! You've got this!** ðŸŽ‰

---

**Package Created**: October 2025  
**Based on**: Demidont & Backus (2025). Bridging the Gap. *Viruses*.  
**Contact**: acdemidont@nyxdynamics.org

**All resources available at**: [Your outputs directory]
